A Study of Palbociclib (PD-0332991) + Letrozole vs. Letrozole For 1st Line Treatment Of Postmenopausal Women With ER+/HER2- Advanced Breast Cancer (PALOMA-2)

NCT01740427 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

666

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Neoplasms

Interventions

DRUG: PD-0332991
DRUG: Letrozole
DRUG: Placebo
DRUG: Letrozole

Sponsor

Pfizer